SCHEMBL5437578

SCHEMBL5437578

CCC(NC(N)=S)OC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28130733 0.80 ALDH1A1 (0.32)
SCHEMBL28069388 0.80 ALDH1A1 (0.32)
SCHEMBL29161033 0.76 CA12 (0.30)
Zinc Ion SCHEMBL29017860 0.76 CA12 (0.48)
SCHEMBL28370418 0.74
SCHEMBL6896586 0.72
SCHEMBL11382557 0.71 MMP1 (0.37)
SCHEMBL10905874 0.70
SCHEMBL11792719 0.70
SCHEMBL1618298 0.70

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070066585-A1 ARYL PHENYLHETEROCYCLYL SULFIDE DERIVATIVES AND THEIR USE AS CELL ADHESION-INHIBITING ANTI-INFLAMMATORY AND IMMUNE-SUPPRESSIVE AGENTS WANG GARY T 2007-03-22 US disclosed
US-7129247-B2 Aryl phenylheterocyclyl sulfide derivatives and their use as cell adhesion-inhibiting anti-inflammatory and immune-suppressive agents ABBOTT LABORATORIES (US) 2006-10-31 US disclosed
US-20050014746-A1 Aryl phenylheterocyclyl sulfide derivatives and their use as cell adhesion-inhibiting anti-inflammatory and immune-supressive agents ICOS CORPORATION 2005-01-20 US disclosed
US-6787542-B2 Aryl phenylheterocyclyl sulfide derivatives and their use as cell adhesion-inhibiting anti-inflammatory and immune-suppressive agents ICOS CORPORATION 2004-09-07 US disclosed
US-20020132807-A1 Aryl phenylheterocyclyl sulfide derivatives and their use as cell adhesion-inhibiting anti-inflammatory and immune-suppressive agents ICOS CORPORATION 2002-09-19 US disclosed